FDA Inspection 1004548 — Penn Pharmaceutical Services Limited
The FDA completed an inspection of Penn Pharmaceutical Services Limited on March 1, 2017 in Tredegar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 1, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Tredegar (United Kingdom)
Additional Details
Postmarket Audit Inspections